ISPE Good Practice Guide - Maintenance 2021 PDF
Name in English:
St ISPE Good Practice Guide - Maintenance 2021
Name in Russian:
Ст ISPE Good Practice Guide - Maintenance 2021
Original standard ISPE Good Practice Guide - Maintenance 2021 in PDF full version. Additional info + preview on request
Full title and description
ISPE Good Practice Guide: Maintenance (2nd Edition, 2021). This practical guidance from the International Society for Pharmaceutical Engineering (ISPE) provides a risk‑based, GMP‑focused approach to establishing and operating maintenance programs for pharmaceutical and biopharmaceutical facilities and equipment. It covers maintenance strategy, planning, execution, documentation, and continuous improvement with examples and best‑practice recommendations tailored to regulated operations.
Abstract
This Good Practice Guide addresses maintenance activities that impact product quality, process compliance, and facility availability in GMP environments. The 2021 second edition aligns maintenance practices with a risk‑based approach (reflecting ICH Q9 principles), consolidates categories of practice, clarifies terminology, and updates practical examples for implementation across maintenance, engineering, quality, and operations functions.
General information
- Status: Active / Current.
- Publication date: January 2021.
- Publisher: ISPE (International Society for Pharmaceutical Engineering).
- ICS / categories: Pharmaceutical engineering; Maintenance & asset management; GMP operations; Quality risk management; Good practice guidance.
- Edition / version: 2nd Edition (2021).
- Number of pages: 132.
Scope
The Guide focuses on maintenance activities performed within GMP areas and on equipment whose state can affect product quality, safety, and regulatory compliance. It covers strategy selection (preventive, predictive, reactive), maintenance planning and execution, documentation and recordkeeping, spare parts and vendor management, maintenance‑related change control and qualification considerations, performance measurement (KPIs), and the application of quality risk management to maintenance decisions. The content is intended to be applicable across a range of pharmaceutical and biopharmaceutical facility types and scales.
Key topics and requirements
- Risk‑based maintenance strategy selection and prioritization (aligned with ICH Q9 concepts).
- Preventive, condition‑based, and predictive maintenance approaches and when to apply each.
- Maintenance planning, work control, and execution practices that preserve GMP compliance.
- Equipment maintenance documentation, records, and evidence for inspections and audits.
- Spare parts strategy, obsolescence management, and vendor/service provider controls.
- Interfaces with validation/qualification, calibration, and change control processes.
- Metrics and KPIs for maintenance performance, reliability, and compliance monitoring.
- Use of digital tools and predictive analytics to support proactive maintenance and reduced downtime.
Typical use and users
Primary users include maintenance managers, engineering leads, quality assurance and quality control personnel, validation engineers, reliability engineers, facility managers, and compliance/regulatory staff within pharmaceutical and biopharmaceutical organizations. The Guide is used to design or update maintenance programs, inform SOPs and procedures, support training, and prepare for inspections or internal audits.
Related standards
Relevant references and complementary guidance include ICH Q9 (Quality Risk Management) principles, ISPE GAMP and other ISPE Good Practice Guides, ISO standards on asset management (ISO 55000 series), and regulatory agency expectations for equipment and facility maintenance in GMP contexts.
Keywords
Maintenance, preventive maintenance, predictive maintenance, condition‑based maintenance, GMP, ICH Q9, equipment qualification, asset management, spare parts, maintenance planning, reliability, ISPE Good Practice Guide.
FAQ
Q: What is this standard?
A: It is the ISPE Good Practice Guide: Maintenance (2nd Edition, 2021) — a non‑regulatory industry guidance document presenting practical, GMP‑focused maintenance practices for pharmaceutical and biopharmaceutical operations.
Q: What does it cover?
A: The Guide covers maintenance strategies and tactics (preventive, predictive, reactive), planning and execution, documentation and records, spare parts and vendor controls, interfaces with validation and change control, risk‑based decision making, performance metrics, and use of digital tools to improve reliability and compliance.
Q: Who typically uses it?
A: Maintenance and reliability engineers, facilities and utilities teams, quality and validation personnel, production and operations managers, and regulatory/compliance staff in pharmaceutical and biotech companies use this Guide to design and run compliant maintenance programs.
Q: Is it current or superseded?
A: As of its publication it is the current (active) second edition published in January 2021. Users should check ISPE for any later revisions or newer Good Practice Guides that may update specific topics.
Q: Is it part of a series?
A: Yes — it is part of ISPE’s portfolio of Good Practice Guides, which provide topic‑focused, practical guidance across pharmaceutical engineering, quality, validation, and manufacturing disciplines.
Q: What are the key keywords?
A: Maintenance, preventive maintenance, predictive maintenance, condition monitoring, GMP, equipment qualification, ICH Q9, asset management, reliability, ISPE Good Practice Guide.